Understand addiction-treatment trials as if they were built for you.
Upload your profile, select a trial, and get a personalized, source-cited simulation — dose timeline, risk flags, and eligibility check — designed to be taken to a clinician, not acted on alone.
Why this exists, right now
The White House announced an Executive Order accelerating research on psychedelic therapies for serious mental illness — with a focus on veterans. The public conversation about protocols, eligibility, and risk is about to get a lot louder, and a lot of it will be noisy.
- FDA National Priority Vouchers for psychedelic candidates with Breakthrough Therapy designation.
- $50M ARPA-H match for state-funded psychedelic research (Texas ibogaine consortium cited).
- HHS, FDA, and VA to collaborate on trial participation pathways for veterans.
- Attorney General directed to open a rescheduling pathway once a Phase 3 trial succeeds.
- Ibogaine accessible via the Right to Try Act for eligible patients.
Source: whitehouse.gov fact sheet. This app is an educational reading aid — not medical advice, not affiliated with any agency, trial sponsor, or physician.
A four-stage pipeline designed around patient safety
Retriever
Pulls the exact protocol, PK/PD facts, and related papers for the selected trial.
Deterministic calculators
Weight-dose, Cockcroft-Gault, Child-Pugh, BSA, QTc — every number from a cited formula.
Guardrail rules
Hard contraindications, DDIs, and eligibility checks before anything reaches the LLM.
Narrative composer
Claude Sonnet explains the pre-computed figures in plain English — never invents doses.
From your story to an informed conversation
Build your profile
Demographics, comorbidities, current medications, and lab values drive the personalization.
Explore trials
Filter active and accelerated psychopharma and psychedelic trials for substance-use disorders.
Simulate for you
See a protocol modelled against your profile: dose schedule, risk flags, and citations.